Comparison of the expression of 5 heat shock proteins in benign and malignant salivary gland tumor tissues

Oncology Letters

Volumn 5, Issue 4, 2013, Pages 1363-1369

  Wang, Guilan ^a   Gu, Xiaolin ^b   Chen, Li ^a   Wang, Yinmei ^b   Cao, Bin ^c   Qun, E ^a  

^a NANTONG MEDICAL COLLEGE   (China)

^b The First People's Hospital of Nantong   (China)

^c Department of Neurosurgery   (China)

Author keywords

Heat shock proteins; Proliferating cell nuclear antigen; Salivary gland tumor; Significance

Indexed keywords

CHAPERONIN 60; CYCLINE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 84; HEAT SHOCK PROTEIN 86; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BENIGN TUMOR; CANCER INVASION; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PROTEIN EXPRESSION; SALIVARY GLAND TUMOR; TUMOR VOLUME; UPREGULATION;

EID: 84874401913     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1166     Document Type: Article

References (26)

1. Khalil AA, Kabapy NF, Deraz SF and Smith C: Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets? Biochim Biophys Acta 1816: 89-104, 2011.
2. Scroggins BT, Robzyk K, Wang D, et al: An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol Cell 25: 151-159, 2007.
3. Kim LS and Kim JH: Heat shock protein as molecular targets for breast cancer therapeutics. J Breast Cancer 14: 167-174, 2011.
4. Park SJ, Kostic M and Dyson HJ: Dynamic interaction of Hsp90 with its client protein p53. J Mol Biol 411: 158-173, 2011.
5. Rerole AL, Gobbo J, De TA, et al: Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy. Cancer Res 71: 484-495, 2011.
6. Guo QY, Yuan M, Peng J, Cui XM, Song G, Sui X and Lu SB: Antitumor activity of mixed heat shock protein/peptide vaccine and cyclophosphamide plus interleukin-12 in mice sarcoma. J Exp Clin Cancer Res 30: 24, 2011.
7. Okui T, Shimo T, Hassan NM, et al: Antitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma. Anticancer Res 31: 1197-1204, 2011.
8. Barnes L, Eveson JW, Reichart P and Sidransky D (eds): World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. IARC Press, Lyon, 209-281, 2005
9. Gibert B, Hadchity E, Czekalla A, et al: Inhibition of heat shock protein 27 (HspBl) tumorigenic functions by peptide aptamers. Oncogene 30: 3672-3681, 2011.
10. Banerjee S, Lin CF, Skinner KA, et al: Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression. Cancer Res 71: 318-327, 2011.
11. Kwon SM, Kim SA, Fujii S, Maeda H, Ahn SG and Yoon JH: Transforming growth factor β31 promotes migration of human periodontal ligament cells through heat shock protein 27 phosphorylation. Biol Pharm Bull 34: 486-489, 2011.
12. Shen G, Liang S, Xu Z, et al: Dowuregulated expression of HSP27 in human low-grade glioma tissues discovered by a quautitative proteomic analysis. Proteomic Sci 26: 17-28, 2010.
13. Quintana FJ and Cohen IR: The HSP60 immune system network. Trends Immunol 32: 89-95, 2011.
14. Cappello F, de Macario EC, Zummo G and Macario AJ: Immunohistochemistry of human Hsp60 in health and disease: from autoimmunity to cancer. Methods Mol Biol 787 245-254, 2011.
15. Xu X, Wang W, Shao W, et al: Heat shock protein-60 expression was significantly correlated with the prognosis of lung adenocar-cinoma. J Surg Oncol 104 598-603, 2011.
16. Kayama M, Nakazawa T, Thanos A, et al: Heat shock protein 70 (HSP70) is critical for the photoreceptor stress response after retinal detachment via modulating anti-apoptotic Akt kinase. Am J Pathol 178: 1080-1091, 2011.
17. Zhang J, Wang K, Zhang J, Liu SS, Dai L and Zhang JY Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma. J Proteome Res 10: 2863-2872, 2011.
18. Kocsis J, Meszaros T, Madaras B, et al: High levels of acute phase proteins and soluble 70 kDa heat shock proteins are independent and additive risk factors for mortality in colorectal cancer. Cell Stress Chaperones 16: 49-55, 2011.
19. Zhu Q, Xu YM, Wang LF, et al: Heat shock protein 70 silencing enhances apoptosis inducing factor-mediated cell death in hepa-tocellular carcinoma HepG2 cells. Cancer Biol Ther 8: 792-798, 2009
20. Beck R, Dejeans N, Glorieux C, et al: Molecular chaperone Hsp90 as a target for oxidant-based anticancer therapies. Curr Med Chem 18: 2816-2825, 2011.
21. Taiyab A and Rao Ch M: HSP90 modulates actin dynamics: inhibition of HSP90 leads to decreased cell motility and impairs invasion. Biochim Biophys Acta 1813: 213-221, 2011.
22. Kubota H, Yamamoto S, Itoh E, et al: Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperones 15: 1003-1011, 2010.
23. Walsh N, Larkin A, Swan N, Conlon K, Dowling P, McDermott R and Clynes M: RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation. Cancer Lett 306: 180-189, 2011.
24. Abike F, Tapisiz OL, Zergeroglu S, Dunder I, Temizkan O and Payasli A: PCNA and Ki-67 in endometrial hyperplasias and evaluation of the potential of malignancy. Eur J Gynaecol Oncol 32: 77-80, 2011.
25. Kato K, Kawashiri S, Yoshizawa K, et al: Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis. J Oral Pathol Med 40: 693-698, 2011.
26. Salinthone S, Ba M, Hanson L, Martin JL, Halayko AJ and Gerthoffer WT: Overexpression of human Hsp27 inhibits serum-induced proliferation in airway smooth muscle myocytes and confers resistance to hydrogen peroxide cytotoxicity Am J Physiol Lung Cell Mol Physiol 293: 1194-1207, 2007